NASDAQ:AMDA - Nasdaq -
0.29
+0.02 (+7.41%)
The current stock price of AMDA is 0.29 null. In the past month the price increased by 3.57%. In the past year, price decreased by -92.68%.
Amedica Corporation is a commercial biomaterial company. It is focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices. The Company market spinal fusion products and are developing products for use in total hip and knee joint replacements. Amedica Corporation is based in Salt Lake City, Utah.
Amedica Corp
1885 WEST 2100 SOUTH
SALT LAKE CITY UT 84119
CEO: B. Sonny Bal
Phone: 801-839-3500
The current stock price of AMDA is 0.29 null. The price increased by 7.41% in the last trading session.
The exchange symbol of Amedica Corp is AMDA and it is listed on the Nasdaq exchange.
AMDA stock is listed on the Nasdaq exchange.
Amedica Corp (AMDA) has a market capitalization of 3.44M null. This makes AMDA a Nano Cap stock.
Amedica Corp (AMDA) has a support level at 0.25 and a resistance level at 0.3. Check the full technical report for a detailed analysis of AMDA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AMDA does not pay a dividend.
Amedica Corp (AMDA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.13).
ChartMill assigns a technical rating of 1 / 10 to AMDA. When comparing the yearly performance of all stocks, AMDA is a bad performer in the overall market: 99.04% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to AMDA. Both the profitability and financial health of AMDA have multiple concerns.
Over the last trailing twelve months AMDA reported a non-GAAP Earnings per Share(EPS) of -3.13. The EPS increased by 78.1% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -131.94% | ||
ROA | -56.73% | ||
ROE | -113.41% | ||
Debt/Equity | 0 |